» Articles » PMID: 37197530

Predictive Value of Clinical Features for Anti-reflux Therapy Response in Suspected Gastroesophageal Reflux-induced Chronic Cough

Overview
Journal J Thorac Dis
Specialty Pulmonary Medicine
Date 2023 May 17
PMID 37197530
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Not all gastroesophageal reflux-induced cough (GERC) patients respond to anti-reflux treatment. It is not certain whether reflux-related symptoms or other clinical characteristics could indicate a successful response to anti-reflux treatment. In this study, we aimed to investigate the relationship between clinical features and anti-reflux response.

Methods: We retrospectively analyzed the clinical characteristics of suspected GERC who had reflux-related symptoms or reflux evidence based on abnormal 24-hour esophageal pH value monitoring, or who had no evidence of other common causes of chronic cough in our chronic cough database with a standard case report form. All patients experienced anti-reflux treatment with proton pump inhibitors (PPIs) plus prokinetic agents for at least 2 weeks and were divided into responders and non-responders based on the treatment response.

Results: Among 241 patients with suspected GERC, 146 (60.6%) showed a successful response. There was no significant difference in regard to the proportion of reflux-related symptoms, and results of 24-hour esophageal pH value monitoring between responders and non-responders. Compared with non-responders, responders had higher proportions of nasal itching (21.2% . 8.4%; P=0.014), tickle in the throat (51.4% 35.8%; P=0.025) and lower proportion of pharyngeal foreign body sensation (32.9% 54.7%; P=0.001). Multivariate analysis showed that nasal itching [hazard ratio (HR): 1.593, 95% confidence interval (CI): 1.025-2.476, P=0.039], tickle in the throat (HR: 1.605, 95% CI: 1.152-2.238, P=0.005), pharyngeal foreign body sensation (HR: 0.499, 95% CI: 0.346-0.720, P<0.001) and sensitivity to at least one cough trigger (HR: 0.480, 95% CI: 0.237-0.973, P=0.042) were associated with the therapeutic response.

Conclusions: Over half of suspected GERC patients benefited from anti-reflux therapy. A few clinical features rather than reflux-related symptoms might indicate a response to anti-reflux treatment. Further study is needed for the predictive value.

Citing Articles

Gastrointestinal bleeding risk factors in type A aortic dissection post-aortic arch replacement.

Hao J, Li J, Zhang H, Chen J, Fang M, Wu M J Thorac Dis. 2024; 16(4):2314-2325.

PMID: 38738230 PMC: 11087617. DOI: 10.21037/jtd-23-1752.

References
1.
Lai K, Huang L, Zhao H, Wu F, Zhen G, Deng H . A multicenter survey on the current status of chronic cough and its impact on quality of life in Guangdong, China. J Thorac Dis. 2022; 14(9):3624-3632. PMC: 9562517. DOI: 10.21037/jtd-21-1737. View

2.
Xu X, Chen Q, Liang S, Lv H, Qiu Z . Comparison of gastroesophageal reflux disease questionnaire and multichannel intraluminal impedance pH monitoring in identifying patients with chronic cough responsive to antireflux therapy. Chest. 2014; 145(6):1264-1270. DOI: 10.1378/chest.13-1634. View

3.
Li N, Chen Q, Wen S, Zhang M, Dong R, Xu X . Diagnostic accuracy of multichannel intraluminal impedance-pH monitoring for gastroesophageal reflux-induced chronic cough. Chron Respir Dis. 2021; 18:14799731211006682. PMC: 8010848. DOI: 10.1177/14799731211006682. View

4.
Hom C, Vaezi M . Extraesophageal manifestations of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2013; 42(1):71-91. DOI: 10.1016/j.gtc.2012.11.004. View

5.
JAMIESON J, Stein H, DeMeester T, Bonavina L, Schwizer W, Hinder R . Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol. 1992; 87(9):1102-11. View